ERYTHROMYCIN OPTHALMIC OINTMENT .5% 3.5GM
Generic: Erythromycin
ERYTHROMYCIN OPTHALMIC OINTMENT .5% 3.5GM
Sign up to see pricing
Licensed pharmacies, clinics, doctor's offices, and veterinary practices get instant account approval
Sign Up — Instant ApprovalDrug Information
Identification
Erythromycin
Erythromycin
ARMAS PHARMACEUTICALS INC.
HUMAN PRESCRIPTION DRUG
Administration
OINTMENT
OPHTHALMIC
ANDA064030
Active Ingredients
| Ingredient | Strength |
|---|---|
| ERYTHROMYCIN | 5 mg/g |
Pharmacological Class
Data sourced from openFDA / DailyMed. For full prescribing information, consult the drug label.
Wholesale compliance resources
Drug Resources
Clinical Drug Information
Indications & Usage
INDICATIONS AND USAGE: For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin. For prophylaxis of ophthalmia neonatorum due to N. gonorrhoeae or C. trachomatis . The effectiveness of erythromycin in the prevention of ophthalmia caused by penicillinase-producing N.gonorrhoeae is not established. For infants born to mothers with clinically apparent gonorrhea, intravenous or intramuscular injections of aqueous crystalline penicillin G should be given; a single dose of 50,000 units for term infants or 20,000 units for infants of low birth weight. Topical prophylaxis alone is inadequate for these infants.
Dosage & Administration
DOSAGE AND ADMINISTRATION: In the treatment of superficial ocular infections, a ribbon approximately 1 cm in length of Erythromycin Opthalmic Ointment should be applied directly to the infected structure up to 6 times daily, depending on the severity of the infection. For prophylaxis of neonatal gonococcal or chlamydial conjunctivitis, a ribbon of ointment approximately 1 cm in length should be instilled into each lower conjunctival sac. The ointment should not be flushed from the eye following instillation. A new tube should be used for each infant.
Adverse Reactions
ADVERSE REACTIONS: The most frequently reported adverse reactions are minor ocular irritations, redness, and hypersensitivity reactions.
Information for Patients
Information for Patients: Avoid contaminating the applicator tip with material from the eye, fingers, or other source.
Clinical data sourced from openFDA drug labeling. For complete prescribing information, consult the full drug label.